BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Miyazaki M, Kimura F, Shimizu H, Yoshidome H, Otuka M, Kato A, Yoshitomi H, Furukawa K, Takeuchi D, Takayashiki T, Suda K, Takano S. One hundred seven consecutive surgical resections for hilar cholangiocarcinoma of Bismuth types II, III, IV between 2001 and 2008. J Hepatobiliary Pancreat Sci 2010;17:470-5. [PMID: 19936600 DOI: 10.1007/s00534-009-0207-2] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 3.6] [Reference Citation Analysis]
Number Citing Articles
1 Yang M, Li WW, Chen JH, Cui MH, Liu JL. The value of caudate lobectomy in hilar cholangiocarcinoma treatment: A meta-analysis. Medicine (Baltimore) 2021;100:e24727. [PMID: 33607815 DOI: 10.1097/MD.0000000000024727] [Reference Citation Analysis]
2 Govil S, Reddy MS, Rela M. Surgical resection techniques for locally advanced hilar cholangiocarcinoma. Langenbecks Arch Surg 2014;399:707-16. [DOI: 10.1007/s00423-014-1216-4] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
3 Hibi T, Shinoda M, Itano O, Kitagawa Y. Current status of the organ replacement approach for malignancies and an overture for organ bioengineering and regenerative medicine. Organogenesis 2014;10:241-9. [PMID: 24836922 DOI: 10.4161/org.29245] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
4 Boland B, Kim A, Nissen N, Colquhoun S. Cholangiocarcinoma: Aggressive Surgical Intervention Remains Justified. The American Surgeon 2012;78:157-60. [DOI: 10.1177/000313481207800231] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
5 Popescu I, Dumitrascu T. Curative-intent surgery for hilar cholangiocarcinoma: prognostic factors for clinical decision making. Langenbecks Arch Surg 2014;399:693-705. [PMID: 24841192 DOI: 10.1007/s00423-014-1210-x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 3.9] [Reference Citation Analysis]
6 Sano T, Shimizu Y, Senda Y, Kinoshita T, Nimura Y. Assessing resectability in cholangiocarcinoma. Hepat Oncol 2014;1:39-51. [PMID: 30190940 DOI: 10.2217/hep.13.6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
7 Akamatsu N, Sugawara Y, Hashimoto D. Surgical strategy for bile duct cancer: Advances and current limitations. World J Clin Oncol 2011; 2(2): 94-107 [PMID: 21603318 DOI: 10.5306/wjco.v2.i2.94] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 35] [Article Influence: 3.3] [Reference Citation Analysis]
8 Neuhaus P, Thelen A, Jonas S, Puhl G, Denecke T, Veltzke-Schlieker W, Seehofer D. Oncological superiority of hilar en bloc resection for the treatment of hilar cholangiocarcinoma. Ann Surg Oncol. 2012;19:1602-1608. [PMID: 21964888 DOI: 10.1245/s10434-011-2077-5] [Cited by in Crossref: 159] [Cited by in F6Publishing: 138] [Article Influence: 14.5] [Reference Citation Analysis]
9 Miyazaki M, Yoshitomi H, Miyakawa S, Uesaka K, Unno M, Endo I, Ota T, Ohtsuka M, Kinoshita H, Shimada K, Shimizu H, Tabata M, Chijiiwa K, Nagino M, Hirano S, Wakai T, Wada K, Isayama H, Okusaka T, Tsuyuguchi T, Fujita N, Furuse J, Yamao K, Murakami K, Yamazaki H, Kijima H, Nakanuma Y, Yoshida M, Takayashiki T, Takada T. Clinical practice guidelines for the management of biliary tract cancers 2015: the 2nd English edition. J Hepatobiliary Pancreat Sci. 2015;22:249-273. [PMID: 25787274 DOI: 10.1002/jhbp.233] [Cited by in Crossref: 119] [Cited by in F6Publishing: 97] [Article Influence: 17.0] [Reference Citation Analysis]
10 Nagino M. Perihilar cholangiocarcinoma: a surgeon’s viewpoint on current topics. J Gastroenterol. 2012;47:1165-1176. [PMID: 22847554 DOI: 10.1007/s00535-012-0628-6] [Cited by in Crossref: 50] [Cited by in F6Publishing: 43] [Article Influence: 5.0] [Reference Citation Analysis]
11 Abbas S, Sandroussi C. Systematic review and meta-analysis of the role of vascular resection in the treatment of hilar cholangiocarcinoma. HPB (Oxford) 2013;15:492-503. [PMID: 23750491 DOI: 10.1111/j.1477-2574.2012.00616.x] [Cited by in Crossref: 63] [Cited by in F6Publishing: 53] [Article Influence: 7.0] [Reference Citation Analysis]
12 Hue JJ, Sugumar K, Markt SC, Mohamed A, Selfridge JE, Bajor D, Rothermel LD, Hardacre JM, Ammori JB, Winter JM, Ocuin LM. Reassessing the role of surgery in the elderly or chronically sick with proximal extrahepatic cholangiocarcinoma. Surgery 2021;169:233-9. [PMID: 33087251 DOI: 10.1016/j.surg.2020.09.011] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Tzedakis S, Sindayigaya R, Dhote A, Marchese U, Barret M, Belle A, Coriat R, Barat M, Soyer P, Fuks D. Perihilar cholangiocarcinoma: What the radiologist needs to know. Diagnostic and Interventional Imaging 2022. [DOI: 10.1016/j.diii.2022.03.001] [Reference Citation Analysis]
14 Berumen J, Hemming A. Vascular Reconstruction in Hepatic Malignancy. Surg Clin North Am 2016;96:283-98. [PMID: 27017865 DOI: 10.1016/j.suc.2015.11.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
15 Soares KC, Kamel I, Cosgrove DP, Herman JM, Pawlik TM. Hilar cholangiocarcinoma: diagnosis, treatment options, and management. Hepatobiliary Surg Nutr. 2014;3:18-34. [PMID: 24696835 DOI: 10.3978/j.issn.2304-3881.2014.02.05] [Cited by in F6Publishing: 46] [Reference Citation Analysis]
16 Bird NT, Manu N, Quinn L, Needham A, Jones R, Fenwick S, Poston G, Palmer D, Malik H. Evaluation of the utility of prognostic models for patients with resected hilar cholangiocarcinoma. HPB 2019;21:1376-84. [DOI: 10.1016/j.hpb.2019.02.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
17 Ohtsubo I, Ajiki T, Hori Y, Murakami S, Shimizu K, Itoh T, Shimizu M, Fukumoto T, Ku Y. Distinctive expression of CD133 between intraductal papillary neoplasms of the bile duct and bile duct adenocarcinomas: CD133 expression in IPNB. Hepatology Research 2012;42:574-82. [DOI: 10.1111/j.1872-034x.2011.00954.x] [Cited by in Crossref: 5] [Article Influence: 0.5] [Reference Citation Analysis]
18 Seehofer D, Kamphues C, Neuhaus P. [Resection of Klatskin tumors]. Chirurg 2012;83:221-8. [PMID: 22406679 DOI: 10.1007/s00104-011-2177-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
19 Liang Y, Wang J, Shi X, Dong J, Gu W. Application of a Gastroduodenal Artery Graft for Reconstruction of the Hepatic Artery during Radical Resection of Hilar Cholangiocarcinoma. Gastroenterol Res Pract 2015;2015:934565. [PMID: 26339239 DOI: 10.1155/2015/934565] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
20 Mekeel KL, Hemming AW. Evolving role of vascular resection and reconstruction in hepatic surgery for malignancy. Hepat Oncol 2014;1:53-65. [PMID: 30190941 DOI: 10.2217/hep.13.5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
21 Anderson JE, Hemming AW, Chang DC, Talamini MA, Mekeel KL. Surgical management trends for cholangiocarcinoma in the USA 1998-2009. J Gastrointest Surg 2012;16:2225-32. [PMID: 22847574 DOI: 10.1007/s11605-012-1980-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
22 Okuda Y, Taura K, Seo S, Yasuchika K, Nitta T, Ogawa K, Hatano E, Uemoto S. Usefulness of operative planning based on 3-dimensional CT cholangiography for biliary malignancies. Surgery. 2015;158:1261-1271. [PMID: 26054319 DOI: 10.1016/j.surg.2015.04.021] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
23 Natsume S, Ebata T, Yokoyama Y, Igami T, Sugawara G, Shimoyama Y, Nagino M. Clinical significance of left trisectionectomy for perihilar cholangiocarcinoma: an appraisal and comparison with left hepatectomy. Ann Surg. 2012;255:754-762. [PMID: 22367444 DOI: 10.1097/sla.0b013e31824a8d82] [Cited by in Crossref: 67] [Cited by in F6Publishing: 27] [Article Influence: 6.7] [Reference Citation Analysis]
24 Hosokawa I, Shimizu H, Yoshitomi H, Furukawa K, Takayashiki T, Miyazaki M, Ohtsuka M. Impact of Biliary Drainage on Multidetector-Row Computed Tomography on R0 Resection of Perihilar Cholangiocarcinoma. World J Surg. 2018;42:3676-3684. [PMID: 29752510 DOI: 10.1007/s00268-018-4654-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
25 Noji T, Miyamoto M, Kubota KC, Shinohara T, Ambo Y, Matsuno Y, Kashimura N, Hirano S. Evaluation of extra capsular lymph node involvement in patients with extra-hepatic bile duct cancer. World J Surg Oncol 2012;10:106. [PMID: 22681770 DOI: 10.1186/1477-7819-10-106] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
26 Sugiyama H, Tsuyuguchi T, Sakai Y, Ohtsuka M, Miyazaki M, Yokosuka O. Potential role of peroral cholangioscopy for preoperative diagnosis of cholangiocarcinoma. Surg Laparosc Endosc Percutan Tech 2012;22:532-6. [PMID: 23238382 DOI: 10.1097/SLE.0b013e3182686178] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
27 Benzing C, Schmelzle M, Atik CF, Krenzien F, Mieg A, Haiden LM, Wolfsberger A, Schöning W, Fehrenbach U, Pratschke J. Factors associated with failure to rescue after major hepatectomy for perihilar cholangiocarcinoma: A 15-year single-center experience. Surgery 2022. [DOI: 10.1016/j.surg.2021.08.057] [Reference Citation Analysis]
28 Kato A, Shimizu H, Ohtsuka M, Yoshidome H, Yoshitomi H, Furukawa K, Takeuchi D, Takayashiki T, Kimura F, Miyazaki M. Surgical resection after downsizing chemotherapy for initially unresectable locally advanced biliary tract cancer: a retrospective single-center study. Ann Surg Oncol. 2013;20:318-324. [PMID: 23149849 DOI: 10.1245/s10434-012-2312-8] [Cited by in Crossref: 75] [Cited by in F6Publishing: 64] [Article Influence: 7.5] [Reference Citation Analysis]
29 Capobianco I, Rolinger J, Nadalin S. Resection for Klatskin tumors: technical complexities and results. Transl Gastroenterol Hepatol. 2018;3:69. [PMID: 30363698 DOI: 10.21037/tgh.2018.09.01] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
30 Lee JH, Hwang DW, Lee SY, Park K, Lee Y. The Proximal Margin of Resected Hilar Cholangiocarcinoma: The Effect of Microscopic Positive Margin on Long-Term Survival. The American Surgeon 2012;78:471-7. [DOI: 10.1177/000313481207800440] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
31 Weiss MJ, Cosgrove D, Herman JM, Rastegar N, Kamel I, Pawlik TM. Multimodal treatment strategies for advanced hilar cholangiocarcinoma. Langenbecks Arch Surg. 2014;399:679-692. [PMID: 24962146 DOI: 10.1007/s00423-014-1219-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
32 Serrablo A, Serrablo L, Alikhanov R, Tejedor L. Vascular Resection in Perihilar Cholangiocarcinoma. Cancers (Basel) 2021;13:5278. [PMID: 34771439 DOI: 10.3390/cancers13215278] [Reference Citation Analysis]
33 Sakata T, Yoshikawa T, Nomi T, Matsuo Y, Kamitani N, Hokuto D, Sho M. Unresectable hilar cholangiocarcinoma treated with chemoradiotherapy: a 9-year survival case. Int Cancer Conf J 2021;10:41-5. [PMID: 33489700 DOI: 10.1007/s13691-020-00445-z] [Reference Citation Analysis]
34 Hosokawa I, Shimizu H, Yoshitomi H, Furukawa K, Takayashiki T, Kuboki S, Koda K, Miyazaki M, Ohtsuka M. Outcomes of left trisectionectomy and right hepatectomy for perihilar cholangiocarcinoma. HPB (Oxford) 2019;21:489-98. [PMID: 30290984 DOI: 10.1016/j.hpb.2018.08.017] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
35 Ku D, Tang R, Pang T, Pleass H, Richardson A, Yuen L, Lam V. Survival outcomes of hepatic resections in Bismuth-Corlette type IV cholangiocarcinoma. ANZ J Surg 2020;90:1604-14. [PMID: 31840387 DOI: 10.1111/ans.15531] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
36 Ethun CG, Lopez-Aguiar AG, Anderson DJ, Adams AB, Fields RC, Doyle MB, Chapman WC, Krasnick BA, Weber SM, Mezrich JD, Salem A, Pawlik TM, Poultsides G, Tran TB, Idrees K, Isom CA, Martin RCG, Scoggins CR, Shen P, Mogal HD, Schmidt C, Beal E, Hatzaras I, Shenoy R, Cardona K, Maithel SK. Transplantation Versus Resection for Hilar Cholangiocarcinoma: An Argument for Shifting Treatment Paradigms for Resectable Disease. Ann Surg. 2018;267:797-805. [PMID: 29064885 DOI: 10.1097/sla.0000000000002574] [Cited by in Crossref: 68] [Cited by in F6Publishing: 33] [Article Influence: 22.7] [Reference Citation Analysis]
37 Matsuyama R, Mori R, Ota Y, Homma Y, Kumamoto T, Takeda K, Morioka D, Maegawa J, Endo I. Significance of Vascular Resection and Reconstruction in Surgery for Hilar Cholangiocarcinoma: With Special Reference to Hepatic Arterial Resection and Reconstruction. Ann Surg Oncol 2016;23:475-84. [PMID: 27387681 DOI: 10.1245/s10434-016-5381-2] [Cited by in Crossref: 29] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
38 Nanashima A, Tobinaga S, Abo T, Sakamoto I, Hayashi H, Sawai T, Takeshita H, Hidaka S, Nagayasu T. Usefulness of measuring hepatic functional volume using technetium-99m galactosyl serum albumin scintigraphy in hilar bile duct carcinoma. Clin J Gastroenterol 2010;3:174-8. [PMID: 26190127 DOI: 10.1007/s12328-010-0151-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
39 Matsuyama R, Morioka D, Mori R, Yabushita Y, Hiratani S, Ota Y, Kumamoto T, Endo I. Our Rationale of Initiating Neoadjuvant Chemotherapy for Hilar Cholangiocarcinoma: A Proposal of Criteria for "Borderline Resectable" in the Field of Surgery for Hilar Cholangiocarcinoma. World J Surg 2019;43:1094-104. [PMID: 30536024 DOI: 10.1007/s00268-018-04883-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
40 Sano T, Shimizu Y, Senda Y, Komori K, Ito S, Abe T, Kinoshita T, Nimura Y. Isolated caudate lobectomy with pancreatoduodenectomy for a bile duct cancer. Langenbecks Arch Surg 2013;398:1145-50. [PMID: 24026222 DOI: 10.1007/s00423-013-1110-5] [Reference Citation Analysis]
41 Noji T, Tsuchikawa T, Okamura K, Shichinohe T, Tanaka E, Hirano S. Surgical Outcome of Hilar Plate Resection: Extended Hilar Bile Duct Resection Without Hepatectomy. J Gastrointest Surg 2014;18:1131-7. [DOI: 10.1007/s11605-014-2490-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
42 Bird NTE, McKenna A, Dodd J, Poston G, Jones R, Malik H. Meta-analysis of prognostic factors for overall survival in patients with resected hilar cholangiocarcinoma. Br J Surg. 2018;105:1408-1416. [PMID: 29999515 DOI: 10.1002/bjs.10921] [Cited by in Crossref: 19] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
43 Higuchi R, Ota T, Yazawa T, Kajiyama H, Araida T, Furukawa T, Yoshikawa T, Takasaki K, Yamamoto M. Improved surgical outcomes for hilar cholangiocarcinoma: changes in surgical procedures and related outcomes based on 40 years of experience at a single institution. Surg Today 2016;46:74-83. [DOI: 10.1007/s00595-015-1119-1] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 3.1] [Reference Citation Analysis]
44 Kamachi H, Kamiyama T, Tsuruga Y, Orimo T, Wakayama K, Shimada S, Kakisaka T, Yokoo H, Yamashita K, Taketomi A. Transparenchymal glissonean approach: a novel surgical technique for advanced perihilar bile duct cancer. Langenbecks Arch Surg 2018;403:387-94. [PMID: 29063245 DOI: 10.1007/s00423-017-1633-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
45 Hosokawa I, Shimizu H, Ohtsuka M, Miyazaki M. Liver Transection-First Approach in Left Trisectionectomy for Perihilar Cholangiocarcinoma. Ann Surg Oncol 2020;27:2381-6. [PMID: 32152773 DOI: 10.1245/s10434-020-08306-y] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]